Sponsor:
Inozyme Pharma
Code:
NCT06046820
Conditions
Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
Autosomal Recessive Hypophosphatemic Rickets
Generalized Arterial Calcification of Infancy
Eligibility Criteria
Sex: All
Age: 1 - 12
Healthy Volunteers: Not accepted
Interventions
INZ-701
Control Arm (Conventional Therapy)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations